Totally agree FDA is working with grants &orphan drug status but for present cures it is still out in time Chemo is a death sentence in most cases
We all have lost loved ones to Cancers
Certainly an interesting 60 minutes piece. It will get fast tracked in the next year most likely. Still I think 1/2 the patients died but that might have been dose levels. We can only hope that it works, or some other option works. If it becomes the definitive cure it will indeed have market repercussions but it is a few years off. NWBO has taken a different yet similar approach to that at Duke and is in phase 3 treating the same brain cancer. The early trials had results as good as those at Duke, but the real bottom line is a cancer cure will happen, and the timeline is years, not decades.
Will it impact arry, or the other small cancer biotechs, absolutely, but not this year or next, but a cure eliminates a bunch of companies over night for sure.
waiting for another PR from RONALD telling us about his famous " upcoming catalyst" comments. If shareholders got a dime for everytime he mentioned it we would be rich. ALL SMOKE AND MIRROS IMO
Encorafenib is a BRAF (an important protein kinase in signaling pathways) inhibitor currently undergoing Phase 3 trials. Mutations in BRAF are found in many cancers, and as such, encorafenib is designed to treat cancers by inhibiting these mutated proteins. The drug has already undergone trials for colorectal cancer and is currently being tested as a melanoma treatment in conjunction with binimetinib, which Array already owns due to an agreement with Novartis early last year. All told, encorafenib is undergoing 11 active clinical trials at the moment.
Sentiment: Strong Buy
A matter ofTime before ARRyis bought out Big Pharma is cutting R&dand will be on Hunt to buy ARRY
They need some new management. Inside of. Yak Yak and A roller coastal ride Get a Real CEO
I had 6 alerts from arrays website on Saturday. all were from employes from the VP on down purchasing shares and they had to notified the sec. ??? So why is it down today ???
Sentiment: Strong Buy
Call what you want NOT a penny spent on buying shares on the open market....says a lot about poor management. CEO Squarer is just a modern snake oil salesman
Agree.. HE OR ANY INSIDER hasn't bought any to back up his 2 interviews. In fact he sold some in March.
You're pathetic. What the hell is DEERATION? And why would Squarer buy shares when he gets a mountain of dirt-cheap stock options?
That is some serious change and dynamic conviction. Glad you have a good bird. My average on buyout cans is such that I quit the strategy entirely. Gotta hand it to you.